EBS SCHEDULE 13G/A: SEC filing
Oak Hill Advisors LP
Filed with the SEC on · accession 0000919574-26-008077
EBS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Oak Hill Advisors LP filed an amended Schedule 13G reporting beneficial ownership of 4,014,015 shares (7.5%) of Emergent BioSolutions common stock, including 2,500,000 shares issuable upon exercise of warrants.
Summary of the filing
Oak Hill Advisors LP filed an amended Schedule 13G reporting beneficial ownership of 4,014,015 shares (7.5%) of Emergent BioSolutions common stock, including 2,500,000 shares issuable upon exercise of warrants. The filing is a passive investment disclosure under Rule 13d-1(b).
Key details
✦ Ask GOAX AI about this filing — what it means for EBS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for EBS?
Click hereFrequently asked questions
What did EBS file with the SEC on Nov 16, 2026?
EBS filed a SCHEDULE 13G/A (SEC filing). Oak Hill Advisors LP filed an amended Schedule 13G reporting beneficial ownership of 4,014,015 shares (7.5%) of Emergent BioSolutions common stock, including 2,500,000 shares issuable upon exercise of warrants. The filing is a passive investment disclosure under Rule 13d-1(b).
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other EBS SEC filings
Get alerts when EBS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days